Literature DB >> 26666256

5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications.

Enzo Lalli1,2,3, Hironobu Sasano4.   

Abstract

Groundbreaking progress has been recently made in elucidating the signaling pathways that are altered in adrenocortical carcinoma (ACC), an endocrine malignancy that still has an unfavorable prognosis, and in understanding its genomic structure. These advances need now to be translated to create cellular and animal models more relevant to human disease in order to develop new and more effective diagnostic procedures and targeted therapies against this deadly malignancy.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26666256     DOI： 10.1007/s12672-015-0240-3

Source DB:  PubMed          Journal:  Horm Cancer        ISSN： 1868-8497            Impact factor:   3.869


  47 in total

1.  Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.

Authors:  Joanne H Heaton; Michelle A Wood; Alex C Kim; Lorena O Lima; Ferdous M Barlaskar; Madson Q Almeida; Maria C B V Fragoso; Rork Kuick; Antonio M Lerario; Derek P Simon; Ibere C Soares; Elisabeth Starnes; Dafydd G Thomas; Ana C Latronico; Thomas J Giordano; Gary D Hammer
Journal:  Am J Pathol       Date:  2012-07-15       Impact factor: 4.307

2.  Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.

Authors:  Jonathan D Wasserman; Ana Novokmet; Claudia Eichler-Jonsson; Raul C Ribeiro; Carlos Rodriguez-Galindo; Gerard P Zambetti; David Malkin
Journal:  J Clin Oncol       Date:  2015-01-12       Impact factor: 44.544

3.  Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

Authors:  Frédérique Tissier; Catherine Cavard; Lionel Groussin; Karine Perlemoine; Gwladys Fumey; Anne-Marie Hagneré; Fernande René-Corail; Eric Jullian; Christine Gicquel; Xavier Bertagna; Marie-Cécile Vacher-Lavenu; Christine Perret; Jérôme Bertherat
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

Review 4.  Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (Mustela putorius furo) and laboratory mouse.

Authors:  M Bielinska; S Kiiveri; H Parviainen; S Mannisto; M Heikinheimo; D B Wilson
Journal:  Vet Pathol       Date:  2006-03       Impact factor: 2.221

5.  Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma.

Authors:  Ferdous M Barlaskar; Aaron C Spalding; Joanne H Heaton; Rork Kuick; Alex C Kim; Dafydd G Thomas; Thomas J Giordano; Edgar Ben-Josef; Gary D Hammer
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

6.  Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists.

Authors:  Mabrouka Doghman; Julie Cazareth; Dominique Douguet; Franck Madoux; Peter Hodder; Enzo Lalli
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

Review 7.  Accessing Genetic Information with Liquid Biopsies.

Authors:  Xuyu Cai; Filip Janku; Qimin Zhan; Jian-Bing Fan
Journal:  Trends Genet       Date:  2015-10       Impact factor: 11.639

8.  Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors.

Authors:  T M A Kerkhofs; M N Kerstens; I P Kema; T P Willems; H R Haak
Journal:  Horm Cancer       Date:  2015-05-19       Impact factor: 3.869

9.  Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition.

Authors:  Aude Salomon; Michelle Keramidas; Cécile Maisin; Michaël Thomas
Journal:  Oncotarget       Date:  2015-05-10

10.  Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models.

Authors:  Coralie Drelon; Annabel Berthon; Bruno Ragazzon; Frédérique Tissier; Roberto Bandiera; Isabelle Sahut-Barnola; Cyrille de Joussineau; Marie Batisse-Lignier; Anne-Marie Lefrançois-Martinez; Jérôme Bertherat; Antoine Martinez; Pierre Val
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240
View more
  2 in total

Review 1.  The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.

Authors:  Maja Mizdrak; Tina Tičinović Kurir; Joško Božić
Journal:  Biomedicines       Date:  2021-02-10

Review 2.  Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers.

Authors:  Yuling Cheng; Wei Kou; Dandan Zhu; Xinbo Yu; Yu Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-01       Impact factor: 5.555
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.